JB Pharma publishes its maiden sustainability report

JB Pharma publishes its maiden sustainability report

Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%

  • By IPP Bureau | October 14, 2022

J B Chemicals & Pharmaceuticals Ltd. (JB Pharma), one of the fastest growing pharma companies in India, published its inaugural Sustainability Report.

The report is prepared following the international reporting standards framework, the Global Reporting Initiative (GRI) as its core standard, and linkages with the Sustainable Development Goals (SDGs). The report reflects on JB Pharma’s commitment to cascading practices across all operations responsible and fostering transparency regarding the company’s progress in its ESG objectives.

“We are proud to share our inaugural Sustainability report. It is an important step in the right direction and in line with our motto of good health for a healthier world. We believe in conducting business in a socially, environmentally, and ethically responsible manner with a defined approach towards environmental protection, natural resource conservation, and cost efficiency to ensure safety & health protection of our employees, communities, & planet at large,” said Nikhil Chopra, CEO, JB Pharma.

“The company adopted a multi-stakeholder approach to determine its expectations about Environment, Social and Governance (ESG) issues. The ESG report focuses on key factors which emerged to be most important for our stakeholders during the materiality assessment of our organisation," added Chopra.

Being a responsible company, JB Pharma has been constantly paving the way for enabling a greener and a cleaner word. Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2% and augmented green energy through solar power. Additionally, its Scope 1 and Scope 2 emissions have reduced by 14.6% and 10.7% during the same period.

Through its clean and green initiatives, JB Pharma has also ensured that its waste is properly disposed of. During the reporting period, waste sent for co-processing stood at 757.65 MT. All sites are Zero Liquid Discharge. While protecting the environment, the organisation has also ensured protection and well–being of its employees.

JB Pharma continuously strives to foster an equitable and desirable work environment through its policies and systems. As a result, the organisation witnessed a 20.6% increase in women workforce across plants from FY 2020 to FY 2022, and 73 female employees working in fields usually dominated by their counterparts in the industry. Its stringent health and safety practices also ensured zero work- related injuries during the year. With a people-centric approach, its CSR interventions continue to positively impact the lives of thousands across the nation.

Upcoming E-conference

Other Related stories